Eight weeks of aromatase inhibition using the nutritional supplement Novedex XT: Effects in young, eugonadal men

International Journal of Sport Nutrition and Exercise Metabolism

Volumn 17, Issue 1, 2007, Pages 92-108

  Willoughby, Darryn S ^a   Wilborn, Colin ^a   Taylor, Lemuel ^a   Campbell, William ^a  

^a BAYLOR UNIVERSITY   (United States)

Author keywords

Body composition; Dihydrotestosterone; Estrogen; Testosterone

Indexed keywords

ANDROSTANE DERIVATIVE; ANDROSTANOLONE; AROMATASE INHIBITOR; ESTROGEN; HYDROXYANDROST 4 ENE 6,17 DIOXO 3 TETRAHYDROPYRANOL ETHER PLUS 3,17 DIKETOANDROST 1,4,6 TRIENE DERIVATIVE; NOVEDEX XT; TESTOSTERONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ENZYME INHIBITION; ESTROGEN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; NUTRITIONAL SUPPORT; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; URINALYSIS; ADIPOSE TISSUE; BLOOD; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; METABOLISM; PHYSIOLOGY; TIME;

ADIPOSE TISSUE; ADULT; ANALYSIS OF VARIANCE; AROMATASE INHIBITORS; BODY COMPOSITION; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; ESTROGENS; HUMANS; MALE; TESTOSTERONE; TIME FACTORS;

EID: 34249659535     PISSN: 1526484X     EISSN: 15432742     Source Type: Journal    
DOI: 10.1123/ijsnem.17.1.92     Document Type: Article

References (22)

1. Bhasin, S., T. Storer, N. Berman, N. Callegari, B. Clevenger, J. Phillips, T. Bunnell, R. Tricker, A. Shirazi, and R. Casaburi. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N. Engl. J. Med. 335(1):1-7, 1996.
2. Bhasin, S., T. Storer, N. Berman, K. Yarasheski, B. Clevenger, J. Phillips, W. Lee, T. Bunnell, and R. Casaburi. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J. Clin. Endocrinol. Metab. 82(2):407-413, 1997.
3. Bross, R., R. Casuburi, T. Storer, and S. Bhasin. Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states. Baillieres Clin. Endocrinol. Metab. 12(3):365-378, 1998.
4. Ferrando, A., K. Tipton, D. Doyle, S. Phillips, J. Cortiella, and R. Wolfe. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am. J. Physiol. 275(5 Pt 1):E864-E871, 1998.
5. Hampl, R., L. Starka, and L. Jansky. Steroids and thermogenesis. Physiol. Res. 55(2):123-131, 2006.
6. Hayes, F. Testosterone: fountain of youth or drug of abuse? J. Clin. Endocrinol. Metab. 85(9):3020-3023, 2000.
7. Hayes, F., S. Seminara, S. Decruz, P. Boepple, W. Crowley. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J. Clin. Endocrinol. Metab. 85(9):3027-3035, 2000.
8. Herbst, K., and S. Bhasin. Testosterone action on skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care. 7(3):271-277, 2004.
9. Holloway, L., G. Butterfield, R. Hintz, N. Gesundheit, and R. Marcus. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J. Clin. Endocrinol. Metab. 79(2):470-479, 1994.
10. Hossian, A., and C. Hornick. Androgenic modulation of lipid metabolism at subcellular sites in cholestatic rats. Horm. Metab. Res. 26(1):19-25, 1994.
11. Ismail, A., and J. Barth. Endocrinology of gynecomastia. Ann. Clin. Biochem. 38(6):597-607, 2001.
12. Jockenhovel, F., C. Bullmann, M. Schubert, E. Vogel, W. Reinhardt, D. Muller-Wieland, and W. Krone. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Metabolism. 48(5):590-596, 1999.
13. Leder, B., J. Rohrer, S. Rubin, J. Gallo, and C. Longcope. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J. Clin. Endocrinol. Metab. 89(3):1174-1180, 2004.
14. Mauras, N., V. Hayes, S. Welch, A. Rini, K. Helgeson, M. Dokler, J. Veldhuis, and R. Urban. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J. Clin. Endocrinol. Metab. 83(6):1886-1892, 1998.
15. Mauras, N., J. Lima, D. Patel, A. Rini, E. diSalle, A. Kwok, and B. Lippe. Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males. J. Clin. Endocrinol. Metab. 88(12):5951-5956, 2003.
16. Mauras, N., K. O'Brien, K. Klein, and V. Hayes. Estrogen suppression in males: metabolic effects. J. Clin. Endocrinol. Metab. 85(7):2370-2377, 2000.
17. Orwoll, E., L. Lambert, L. Marshall, K. Phipps, J. Blank, E. Barrett-Connor, J. Cauley, K. Ensrud, and S. Cummings. Testosterone and estradiol among older men. J. Clin. Endocrinol. Metab. 91(4):1336-1344, 2006.
18. Plourde, P., E. Reiter, J. Hann-Chang, P. Descochers, S. Rubin, B. Bercu, F. Diamond, and B. Backeljauw. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89(9):4428-4433, 2004.
19. Simpson, E. Genetic mutations resulting in estrogen insufficiency in the male. Mol. Cell. Endocrinol. 145(1-2):55-59, 1998.
20. Snyder, P., H. Peachey, P. Hannoush, J. Berlin, L. Loh, D. Lenrow, J. Holmes, A. Dlewati, J. Santanna, C. Rosen, and B. Strom. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 84(8):2647-2653, 1999.
21. Taxel, P., D. Kennedy, P. Fall, A. Willard, J. Clive, and L. Raisz. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J. Clin. Endocrinol. Metab. 86(6):2869-2874, 2001.
22. Zumoff, B., G. Strain, L. Miller, W. Rosner, R. Senie, D. Seres, and R. Rosenfeld. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 71(4):929-931, 1990.